AMRN logo

Amarin (AMRN) Company Overview

Profile

Full Name:

Amarin Corporation plc

Sector:

Healthcare

Country:

Ireland

IPO:

April 1, 1993

Indexes:

Not included

Description:

Amarin Corporation (AMRN) is a biopharmaceutical company focused on developing and commercializing innovative therapies for cardiovascular diseases. Its main product, Vascepa, is used to reduce cardiovascular risk in patients with high triglyceride levels. The company aims to improve heart health through scientific research and effective treatments.

Key Details

Price

$0.54

Annual Revenue

$306.91 M(-16.87% YoY)

Annual EPS

-$0.15(+42.31% YoY)

Annual ROE

-10.30%

Beta

1.08

Events Calendar

Earnings

Next earnings date:

Mar 12, 2025

Recent quarterly earnings:

Oct 30, 2024

Recent annual earnings:

Feb 29, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jan 18, 2008

Analyst ratings

Recent major analysts updates

Jun 20, 24 Cantor Fitzgerald
Overweight
Jun 18, 24 Cantor Fitzgerald
Overweight
Oct 25, 23 Jefferies
Hold
Jul 20, 23 Goldman Sachs
Sell
Jul 19, 23 Northland Capital Markets
Market Perform
Jan 6, 23 Jefferies
Buy
Oct 19, 22 SVB Leerink
Market Perform
May 24, 22 Goldman Sachs
Sell
May 6, 22 JP Morgan
Underweight
May 5, 22 SVB Leerink
Market Perform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Amarin?
  • Does Amarin pay dividends?
  • What sector is Amarin in?
  • What industry is Amarin in?
  • What country is Amarin based in?
  • When did Amarin go public?
  • Is Amarin in the S&P 500?
  • Is Amarin in the NASDAQ 100?
  • Is Amarin in the Dow Jones?
  • When was Amarin's last earnings report?
  • When does Amarin report earnings?
  • Should I buy Amarin stock now?

What is the ticker symbol for Amarin?

The ticker symbol for Amarin is NASDAQ:AMRN

Does Amarin pay dividends?

No, Amarin does not pay dividends

What sector is Amarin in?

Amarin is in the Healthcare sector

What industry is Amarin in?

Amarin is in the Drug Manufacturers - General industry

What country is Amarin based in?

Amarin is headquartered in Ireland

When did Amarin go public?

Amarin's initial public offering (IPO) was on April 1, 1993

Is Amarin in the S&P 500?

No, Amarin is not included in the S&P 500 index

Is Amarin in the NASDAQ 100?

No, Amarin is not included in the NASDAQ 100 index

Is Amarin in the Dow Jones?

No, Amarin is not included in the Dow Jones index

When was Amarin's last earnings report?

Amarin's most recent earnings report was on Oct 30, 2024

When does Amarin report earnings?

The next expected earnings date for Amarin is Mar 12, 2025

Should I buy Amarin stock now?

As of today, analysts generally recommend a 'Sell' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions